Phylogenetic analysis of dysbiosis in ulcerative colitis during remission - PubMed (original) (raw)
Phylogenetic analysis of dysbiosis in ulcerative colitis during remission
Mirjana Rajilić-Stojanović et al. Inflamm Bowel Dis. 2013 Mar.
Abstract
Background: Presence of intestinal microbes is a prerequisite for the development of ulcerative colitis (UC), although deviation of the normal intestinal microbiota composition, dysbiosis, is presumably implicated in the etiology of UC.
Methods: The fecal microbiota of 30 UC samples obtained from 15 patients who were sampled twice and from 15 healthy control subjects originating from 2 geographic locations was analyzed using highly reproducible phylogenetic microarray that has the capacity for detection and quantification of more than 1000 intestinal bacteria in a wide dynamic range.
Results: The fecal microbiota composition is not significantly influenced by geographic location, age, or gender, but it differs significantly between the patients with UC and the control subjects (P = 0.0004). UC-associated microbiota is stable during remission and similar among all patients with UC. Significant reduction of bacterial diversity of members of the Clostridium cluster IV and significant reduction in the abundance of bacteria involved in butyrate and propionate metabolism, including Ruminococcus bromii et rel. Eubacterium rectale et rel., Roseburia sp., and Akkermansia sp. are markers of dysbiosis in UC. Increased abundance of (opportunistic) pathogens including Fusobacterium sp., Peptostreptococcus sp., Helicobacter sp., and Campylobacter sp. as well as Clostridium difficile were found to be associated with UC.
Conclusions: Dysbiosis in UC is stable in time and shared between patients from different geographic locations. The microbial alterations offer a mechanistic insight into the pathogenesis of the disease.
Similar articles
- Alteration of intestinal dysbiosis by fecal microbiota transplantation does not induce remission in patients with chronic active ulcerative colitis.
Kump PK, Gröchenig HP, Lackner S, Trajanoski S, Reicht G, Hoffmann KM, Deutschmann A, Wenzl HH, Petritsch W, Krejs GJ, Gorkiewicz G, Högenauer C. Kump PK, et al. Inflamm Bowel Dis. 2013 Sep;19(10):2155-65. doi: 10.1097/MIB.0b013e31829ea325. Inflamm Bowel Dis. 2013. PMID: 23899544 - A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis.
Machiels K, Joossens M, Sabino J, De Preter V, Arijs I, Eeckhaut V, Ballet V, Claes K, Van Immerseel F, Verbeke K, Ferrante M, Verhaegen J, Rutgeerts P, Vermeire S. Machiels K, et al. Gut. 2014 Aug;63(8):1275-83. doi: 10.1136/gutjnl-2013-304833. Epub 2013 Sep 10. Gut. 2014. PMID: 24021287 - Partners of patients with ulcerative colitis exhibit a biologically relevant dysbiosis in fecal microbial metacommunities.
Chen GL, Zhang Y, Wang WY, Ji XL, Meng F, Xu PS, Yang NM, Ye FQ, Bo XC. Chen GL, et al. World J Gastroenterol. 2017 Jul 7;23(25):4624-4631. doi: 10.3748/wjg.v23.i25.4624. World J Gastroenterol. 2017. PMID: 28740351 Free PMC article. - Enteric microbiota leads to new therapeutic strategies for ulcerative colitis.
Chen WX, Ren LH, Shi RH. Chen WX, et al. World J Gastroenterol. 2014 Nov 14;20(42):15657-63. doi: 10.3748/wjg.v20.i42.15657. World J Gastroenterol. 2014. PMID: 25400449 Free PMC article. Review. - Role and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients: An update.
Scaldaferri F, Gerardi V, Mangiola F, Lopetuso LR, Pizzoferrato M, Petito V, Papa A, Stojanovic J, Poscia A, Cammarota G, Gasbarrini A. Scaldaferri F, et al. World J Gastroenterol. 2016 Jun 28;22(24):5505-11. doi: 10.3748/wjg.v22.i24.5505. World J Gastroenterol. 2016. PMID: 27350728 Free PMC article. Review.
Cited by
- Stable biomarker discovery in multi-omics data via canonical correlation analysis.
Pusa T, Rousu J. Pusa T, et al. PLoS One. 2024 Sep 9;19(9):e0309921. doi: 10.1371/journal.pone.0309921. eCollection 2024. PLoS One. 2024. PMID: 39250478 Free PMC article. - Modified Gegen Qinlian Decoction modulated the gut microbiome and bile acid metabolism and restored the function of goblet cells in a mouse model of ulcerative colitis.
Huang J, Zhang J, Wang F, Tang X. Huang J, et al. Front Immunol. 2024 Aug 6;15:1445838. doi: 10.3389/fimmu.2024.1445838. eCollection 2024. Front Immunol. 2024. PMID: 39165355 Free PMC article. - The human microbiome in space: parallels between Earth-based dysbiosis, implications for long-duration spaceflight, and possible mitigation strategies.
Etlin S, Rose J, Bielski L, Walter C, Kleinman AS, Mason CE. Etlin S, et al. Clin Microbiol Rev. 2024 Sep 12;37(3):e0016322. doi: 10.1128/cmr.00163-22. Epub 2024 Aug 13. Clin Microbiol Rev. 2024. PMID: 39136453 Review. - Successful Manipulation of the Gut Microbiome to Treat Spontaneous and Induced Murine Models of Colitis.
Movva R, Murtaza N, Giri R, Png CW, Davies J, Alabbas S, Oancea I, O'Cuiv P, Morrison M, Begun J, Florin TH. Movva R, et al. Gastro Hep Adv. 2022 Mar 30;1(3):359-374. doi: 10.1016/j.gastha.2021.12.008. eCollection 2022. Gastro Hep Adv. 2022. PMID: 39131681 Free PMC article. - The influence of Akkermansia muciniphila on intestinal barrier function.
Mo C, Lou X, Xue J, Shi Z, Zhao Y, Wang F, Chen G. Mo C, et al. Gut Pathog. 2024 Aug 3;16(1):41. doi: 10.1186/s13099-024-00635-7. Gut Pathog. 2024. PMID: 39097746 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical